100242-41-9 (6-壬烯酸,8-[(2S,2'R,3R,4'S,5S,5'R,7R,7'R,8R,9S,10'R)-9-羟基-2,4',8,10'-四甲基-2'-[(2S,3S,5R,6R)-四氢-6-羟基-6-(羟甲基)-3,5-二甲基-2H-吡喃-2-基]-3-[(2S,5S,6R)-四氢-5-甲氧基-6-甲基-2H-吡喃-2-基]氧基][2,7'-双-1,6-二氧杂螺[4.5]癸基]-7-基]-2,4,6-三甲基-5-氧代-(2S,4R,6E,8S)-,6-Nonenoic acid,8-[(2S,2'R,3R,4'S,5S,5'R,7R,7'R,8R,9S,10'R)-9-hydroxy-2,4',8,10'-tetramethyl-2'-[(2S,3S,5R,6R)-tetrahydro-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-2H-pyran-2-yl]-3-[[(2S,5S,6R)-tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl]oxy][2,7'-bi-1,6-dioxaspiro[4.5]dec]-7-yl]-2,4,6-trimethyl-5-oxo-,(2S,4R,6E,8S)-)

CAS号:
100242-41-9
中文名称:
6-壬烯酸,8-[(2S,2'R,3R,4'S,5S,5'R,7R,7'R,8R,9S,10'R)-9-羟基-2,4',8,10'-四甲基-2'-[(2S,3S,5R,6R)-四氢-6-羟基-6-(羟甲基)-3,5-二甲基-2H-吡喃-2-基]-3-[(2S,5S,6R)-四氢-5-甲氧基-6-甲基-2H-吡喃-2-基]氧基][2,7'-双-1,6-二氧杂螺[4.5]癸基]-7-基]-2,4,6-三甲基-5-氧代-(2S,4R,6E,8S)-
英文名称:
6-Nonenoic acid,8-[(2S,2'R,3R,4'S,5S,5'R,7R,7'R,8R,9S,10'R)-9-hydroxy-2,4',8,10'-tetramethyl-2'-[(2S,3S,5R,6R)-tetrahydro-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-2H-pyran-2-yl]-3-[[(2S,5S,6R)-tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl]oxy][2,7'-bi-1,6-dioxaspiro[4.5]dec]-7-yl]-2,4,6-trimethyl-5-oxo-,(2S,4R,6E,8S)-
分子式:
C47H78O14
分子量:
867.113836765289

6-壬烯酸,8-[(2S,2'R,3R,4'S,5S,5'R,7R,7'R,8R,9S,10'R)-9-羟基-2,4',8,10'-四甲基-2'-[(2S,3S,5R,6R)-四氢-6-羟基-6-(羟甲基)-3,5-二甲基-2H-吡喃-2-基]-3-[(2S,5S,6R)-四氢-5-甲氧基-6-甲基-2H-吡喃-2-基]氧基][2,7'-双-1,6-二氧杂螺[4.5]癸基]-7-基]-2,4,6-三甲基-5-氧代-(2S,4R,6E,8S)-(100242-41-9)名称与标识符

名称

英文别名:
6-Nonenoic acid,8-[(2S,2'R,3R,4'S,5S,5'R,7R,7'R,8R,9S,10'R)-9-hydroxy-2,4',8,10'-tetramethyl-2'-[(2S,3S,5R,6R)-tetrahydro-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-2H-pyran-2-yl]-3-[[(2S,5S,6R)-tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl]oxy][2,7'-bi-1,6-dioxaspiro[4.5]dec]-7-yl]-2,4,6-trimethyl-5-oxo-,(2S,4R,6E,8S)-;endusamycin;(2S,4R,6E,8S)-8-[(2S,2'R,3R,4'S,5S,7R,7'R,8R,9S,10'R)-9-hydroxy-2'-[(2R,3R,5S,6S)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyltetrahydro-2H-pyran-2-yl]-3-{[(2S,5S,6R)-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-2,4',8,10'-tetramethyl-2,7'-bi(1,6-dioxaspiro[4.5]decan)-7-yl]-2,;CP 63517;Dianemycin, 19-de((tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl)oxy)-15-((tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl)oxy)-, (15(2S,5S,6R))-;CP-63517;Q27293800;XE5GN2P1IT;100242-41-9;UNII-XE5GN2P1IT;(E,2S,4R,8S)-8-[(2S,3R,5S,7S,8R,9R)-7-hydroxy-2-[(2R,4S,5R,6R,9R)-2-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-4,6-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-[(2S,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-2,4,6-trimethyl-5-oxonon-6-enoic acid;

标识符

InChIKey:
IXZQKHXEQYZXTP-RATZTJMHSA-N
Inchi:
1S/C47H78O14/c1-24(40(50)25(2)18-28(5)43(51)52)17-26(3)41-32(9)34(49)21-45(59-41)22-38(56-39-16-14-35(54-12)33(10)55-39)44(11,61-45)37-15-13-29(6)47(58-37)31(8)20-36(57-47)42-27(4)19-30(7)46(53,23-48)60-42/h17,25-39,41-42,48-49,53H,13-16,18-23H2,1-12H3,(H,51,52)/b24-17+/t25-,26+,27+,28+,29-,30-,31+,32-,33-,34+,35+,36-,37-,38-,39+,41-,42+,44-,45+,46+,47-/m1/s1
SMILES:
O1[C@H](CC[C@@H](C)[C@@]21[C@@H](C)C[C@H]([C@@H]1[C@@H](C)C[C@@H](C)[C@@](CO)(O)O1)O2)[C@]1(C)[C@@H](C[C@]2(C[C@@H]([C@@H](C)[C@@H]([C@H](/C=C(\C)/C([C@H](C)C[C@@H](C(=O)O)C)=O)C)O2)O)O1)O[C@H]1CC[C@@H]([C@@H](C)O1)OC

6-壬烯酸,8-[(2S,2'R,3R,4'S,5S,5'R,7R,7'R,8R,9S,10'R)-9-羟基-2,4',8,10'-四甲基-2'-[(2S,3S,5R,6R)-四氢-6-羟基-6-(羟甲基)-3,5-二甲基-2H-吡喃-2-基]-3-[(2S,5S,6R)-四氢-5-甲氧基-6-甲基-2H-吡喃-2-基]氧基][2,7'-双-1,6-二氧杂螺[4.5]癸基]-7-基]-2,4,6-三甲基-5-氧代-(2S,4R,6E,8S)-(100242-41-9)物化性质

实验特性

  • LogP : 6.14960
  • PSA : 188.9
  • 折射率 : 1.549
  • 沸点 : 910.3°Cat760mmHg
  • 闪点 : 256.4°C
  • 密度 : 1.21

计算特性

  • 精确分子量 : 866.53934
  • 氢键供体数量 : 4
  • 氢键受体数量 : 14
  • 可旋转化学键数量 : 13
  • 同位素质量 : 866.539157
  • 重原子数量 : 61
  • 复杂度 : 1570
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 20
  • 不确定原子立构中心数量 : 1
  • 确定化学键立构中心数量 : 1
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 5.8
  • 拓扑分子极性表面积 : 189

6-壬烯酸,8-[(2S,2'R,3R,4'S,5S,5'R,7R,7'R,8R,9S,10'R)-9-羟基-2,4',8,10'-四甲基-2'-[(2S,3S,5R,6R)-四氢-6-羟基-6-(羟甲基)-3,5-二甲基-2H-吡喃-2-基]-3-[(2S,5S,6R)-四氢-5-甲氧基-6-甲基-2H-吡喃-2-基]氧基][2,7'-双-1,6-二氧杂螺[4.5]癸基]-7-基]-2,4,6-三甲基-5-氧代-(2S,4R,6E,8S)-(100242-41-9)相关文献